Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 oct. 2025 07h00 HE | Source: BPGbio

BPGbio Presents Phase 2 Glioblastoma Data on BPM31510 at ESMO 2025

BPGbio has completed phase 2b enrollment in late August this year for treatment of GBM with BPM31510Data further validate the MOA of BPM31510’s direct targeting of mitochondrial redox machinery to...
16 oct. 2025 04h00 HE | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV, FSE: 7JO0), a biopharmaceutical company advancing cancer...
15 oct. 2025 16h15 HE | Source: Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million

WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody...
15 oct. 2025 13h00 HE | Source: DelveInsight Business Research LLP

Global Smart Medical Devices Market Poised to Expand at a CAGR of ~12% with Technological Advancements and Increased Adoption | DelveInsight

New York, USA, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Global Smart Medical Devices Market Poised to Expand at a CAGR of ~12% with Technological Advancements and Increased Adoption | DelveInsight The...
15 oct. 2025 09h15 HE | Source: Artelo Biosciences

Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit

ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed or Fasted Conditions ART27.13 Interim Phase 2 Data Showed Substantial...
15 oct. 2025 09h00 HE | Source: Precedence Research

mRNA Therapeutics CDMO Market Grows at 11.37% CAGR to Hit USD 13.63 Bn by 2034

Ottawa, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The global mRNA therapeutics CDMO market size was valued at USD 4.62 billion in 2024 and is predicted to hit around USD 13.63 billion by 2034, rising at a...
15 oct. 2025 08h30 HE | Source: Akari Therapeutics Plc

Akari Therapeutics Announces $2.5 Million Registered Direct Offering

BOSTON and LONDON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company developing novel payload antibody drug conjugates...
15 oct. 2025 02h30 HE | Source: Curium

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

PARIS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., a registrational Phase 2 clinical trial has been initiated in Japan...
14 oct. 2025 11h38 HE | Source: Precedence Research

Infection Control Surveillance Solutions Market Size Worth USD 3,046.65 Mn by 2034

Ottawa, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The global infection control surveillance solutions market size is expected to be worth over USD 3,046.65 million by 2034, increasing from USD 1,077.18...
14 oct. 2025 10h10 HE | Source: SNS Insider pvt ltd

Electrophysiology Market Size to Hit USD 33.72 Billion by 2033, Fueled by Advances in Cardiac Mapping and Minimally Invasive Treatment – SNS Insider

Austin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Electrophysiology Market Size & Growth Outlook According to SNS Insider, the Global Electrophysiology Market was valued at USD 12.89 billion in 2025E...

Page précédente

Page suivante